MedTrace Logo

Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain

NCT00550654 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2017-01-13

Study results available
· View outcomes & findings →

Summary

RATIONALE: Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.

PURPOSE: This phase II trial is studying how well conformal radiation therapy works in treating patients with metastatic cancer outside the brain.

Conditions

Interventions

OTHER

questionnaire administration

Patients complete a pain assessment questionnaire, Brief Pain Inventory at baseline and at 1 and 3 months after treatment.

RADIATION

3-dimensional conformal radiation therapy

Conformal radiation therapy improves the ability to spare normal tissues.

RADIATION

hypofractionated radiation therapy

Hypofractionated radiation therapy is delivered to maximize pain relief while minimizing patient impact if life expectancy is short.

RADIATION

image-guided radiation therapy

Image guided radiation therapy targets the specific site of disease.

RADIATION

tomotherapy

Tomotherapy is a delivery method which provides megavoltage computed tomography (CT) localization and may provide superior conformality and localization compared to other dynamic intensity modulated radiation therapy techniques.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • National Institutes of Health Clinical Center (CC)

    lead NIH

Principal Investigators

  • Deborah E. Citrin, MD · NCI - Radiation Oncology Branch; ROB

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00550654 on ClinicalTrials.gov